Which companies overlap with International Antiviral Therapy Evaluation Center's portfolio?

Top competitors by shared drug class: Baqiyatallah Medical Sciences University, Bristol-Myers Squibb, Community Research Initiative of New England, Drugs for Neglected Diseases, DualityBio Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/international-antiviral-therapy-evaluation-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

International Antiviral Therapy Evaluation Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

International Antiviral Therapy Evaluation Center pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
saquinavir/ritonavir	saquinavir/ritonavir	marketed	HIV protease inhibitor	HIV protease	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Baqiyatallah Medical Sciences University · 1 shared drug class
Bristol-Myers Squibb · 1 shared drug class
Community Research Initiative of New England · 1 shared drug class
Drugs for Neglected Diseases · 1 shared drug class
DualityBio Inc. · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Far East Bio-Tec Co., Ltd · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for International Antiviral Therapy Evaluation Center:

Cite this brief

Drug Landscape (2026). International Antiviral Therapy Evaluation Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/international-antiviral-therapy-evaluation-center. Accessed 2026-05-17.